Optimized Ribociclib nanostructured lipid carrier for the amelioration of skin cancer: Inferences from ex-vivo skin permeation and dermatokinetic studies

Mohammed F. Aldawsari; Mohammad Azhar Kamal; Mohamed F. Balaha; Talha Jawaid; Mohammed Jafar; Sana Hashmi; Majid Ahmad Ganaie; Aftab Alam

doi:10.1016/j.jsps.2024.101984

Q1 2024

Optimized Ribociclib nanostructured lipid carrier for the amelioration of skin cancer: Inferences from ex-vivo skin permeation and dermatokinetic studies

Mohammed F. Aldawsari · Mohammad Azhar Kamal · Mohamed F. Balaha · Talha Jawaid · Mohammed Jafar · Sana Hashmi · Majid Ahmad Ganaie · Aftab Alam

10.1016/j.jsps.2024.101984 385 Views 16 Citations

Citations

385

Views

Abstract not available for this publication.

Cite this Article (APA)

Mohammed, F. A., Mohammad, A. K., Mohamed, F. B., Talha, J., Mohammed, J., Sana, H., Majid, A. G., Aftab, A. (2024). Optimized Ribociclib nanostructured lipid carrier for the amelioration of skin cancer: Inferences from ex-vivo skin permeation and dermatokinetic studies. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.101984